Published in Schizophr Res on December 01, 2010
Disentangling the attention network test: behavioral, event related potentials, and neural source analyses. Front Hum Neurosci (2014) 0.84
Neural correlates of alerting and orienting impairment in multiple sclerosis patients. PLoS One (2014) 0.81
Single-subject prediction of response inhibition behavior by event-related potentials. J Neurophysiol (2015) 0.79
Neurocognitive pattern analysis reveals classificatory hierarchy of attention deficits in schizophrenia. Schizophr Bull (2013) 0.76
Frontal Theta Dynamics during Response Conflict in Long-Term Mindfulness Meditators. Front Hum Neurosci (2017) 0.75
Event-Related Potentials Altered in Patients with Borderline Personality Disorder during Working Memory Tasks. Front Behav Neurosci (2017) 0.75
Multiple Electrophysiological Markers of Visual-Attentional Processing in a Novel Task Directed toward Clinical Use. J Ophthalmol (2012) 0.75
Event-related potentials (ERPs) and hemodynamic (functional near-infrared spectroscopy, fNIRS) as measures of schizophrenia deficits in emotional behavior. Front Psychol (2015) 0.75
Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression. J ECT (2011) 1.42
Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. J Clin Psychiatry (2010) 1.16
Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res (2004) 1.12
Event-related potentials associated with Attention Network Test. Int J Psychophysiol (2010) 1.03
Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry (2010) 1.01
Pregabalin versus pramipexole for restless legs syndrome. N Engl J Med (2014) 0.96
Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics (2008) 0.95
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. J Psychiatr Res (2006) 0.93
Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test. Schizophr Bull (2008) 0.90
Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler (2010) 0.89
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics (2010) 0.88
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis. J Clin Psychopharmacol (2004) 0.87
Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res (2006) 0.86
Region-specific glutamate changes in patients with unipolar depression. J Psychiatr Res (2012) 0.86
Attention Network Test reveals alerting network dysfunction in multiple sclerosis. Mult Scler (2009) 0.86
Variation in the NMDA receptor 2B subunit gene GRIN2B is associated with differential language lateralization. Behav Brain Res (2011) 0.85
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol (2010) 0.84
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia. Psychiatry Res (2009) 0.84
Single-subject classification of schizophrenia by event-related potentials during selective attention. Neuroimage (2010) 0.84
Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med (2014) 0.84
Effects of smoking history on selective attention in schizophrenia. Neuropharmacology (2012) 0.82
Eosinophilia indicating subclinical clozapine-induced pericarditis. J Clin Psychiatry (2007) 0.81
Dichotic listening revisited: trial-by-trial ERP analyses reveal intra- and interhemispheric differences. Neuropsychologia (2008) 0.80
Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. J Psychiatr Res (2010) 0.80
Dissection of early bottom-up and top-down deficits during visual attention in schizophrenia. Clin Neurophysiol (2010) 0.79
Smoking reduces language lateralization: a dichotic listening study with control participants and schizophrenia patients. Brain Cogn (2011) 0.79
Test-retest reliability of Attention Network Test measures in schizophrenia. Schizophr Res (2011) 0.79
Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects. Schizophr Res (2009) 0.79
Smoking improves divided attention in schizophrenia. Psychopharmacology (Berl) (2014) 0.79
Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder. J Neuropsychiatry Clin Neurosci (2006) 0.78
Modification of tyrosine hydroxylase activity by chloral derived beta-carbolines in vitro. J Neurochem (2002) 0.77
Motor cortical excitability in depressive patients after electroconvulsive therapy and repetitive transcranial magnetic stimulation. J ECT (2005) 0.77
Evidence for impaired visual prediction error in schizophrenia. Schizophr Res (2013) 0.77
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms? J Clin Psychopharmacol (2005) 0.77
Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study. Psychiatr Danub (2013) 0.76
Spatiotemporal mapping of sex differences during attentional processing. Hum Brain Mapp (2009) 0.76
Are new drugs for schizophrenia better than old ones? Lancet (2009) 0.75
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2009) 0.75
Homocysteine lowering and cognitive performance. N Engl J Med (2006) 0.75
Escitalopram, problem-solving therapy, and poststroke depression. JAMA (2008) 0.75
Fluoxetine for treatment of anorexia nervosa. JAMA (2006) 0.75
Antipsychotic drugs and schizophrenia. N Engl J Med (2006) 0.75
Electroconvulsive therapy for depression. N Engl J Med (2008) 0.75
Neuron number in children with autism. JAMA (2012) 0.75
Exploring the time course of N170 repetition suppression: a preliminary study. Int J Psychophysiol (2012) 0.75
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride. J Clin Psychopharmacol (2007) 0.75
[New strategies in schizophrenia: impact of endophentotypes]. Psychiatr Prax (2004) 0.75
Hypothalamus - Pituitary - Adrenocortical Dysfunction in Elderly, Male Marathon Runners: Feedback Sensitivity, Stress Response and Effects on Verbal Memory. Neuroendocrinology (2016) 0.75
Mutation analysis of the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome. J Clin Psychopharmacol (2004) 0.75
Tadalafil in a patient with treatment-resistant depression and antidepressant polypharmacy. J Clin Psychopharmacol (2005) 0.75
Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness. Schizophr Res (2011) 0.75
[Neurocognition, psychosocial outcome and vocational integration]. Psychiatr Prax (2004) 0.75
Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines. FEBS J (2008) 0.75